Resveratrol: Phytoestrogen effects on reproductive physiology and behavior in female rats

被引:71
作者
Henry, LA [1 ]
Witt, DM [1 ]
机构
[1] SUNY Binghamton Univ, Dept Psychol, Behavioral Neurosci Program, Binghamton, NY 13902 USA
关键词
endocrine disrupting chemicals (EDCs); sexual behavior; ovarian hypertrophy;
D O I
10.1006/hbeh.2001.1754
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Resveratrol is a phytoestrogen naturally found in grapes and is a major constituent of wine thought to exert both cardioprotective and chemopreventive activities. Recent studies show that this bioflavonoid binds to and activates gene transcription via the estrogen receptor (ER) subtypes ERalpha and ERbeta. Previous studies have focused primarily on the in vitro effects of resveratrol (RES) in estrogen-sensitive tissues or in carcinogenic cell lines, while frequently neglecting to document its potential effects in animal models with intact neuroendocrine systems. However, the present studies were designed to systematically characterize the in vivo effects of RES on reproductive physiology and behavior in adult female rats. In gonadally intact females, RES consumption reduced body weight, disrupted estrous cyclicity, and induced ovarian hypertrophy. However, in ovariectornized females RES (10-1000 mug) injections did not appear to mimic 17 beta-estradiol benzoate (EB)-induced behavioral responses and had no lasting effects on subsequent estrogen sensitivity or sociosexual behavior. The present studies support recent in vitro findings that RES differs from other phytoestrogens by acting as a possible mixed agonist/antagonist, depending on the availability of specific ER isoforms localized in the reproductive tract and brain of the female rat. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:220 / 228
页数:9
相关论文
共 31 条
  • [1] [Anonymous], 1994, PHYSL REPROD, DOI DOI 10.1002/MRD.1080380414
  • [2] Ashby J, 1999, J APPL TOXICOL, V19, P39, DOI 10.1002/(SICI)1099-1263(199901/02)19:1&lt
  • [3] 39::AID-JAT534&gt
  • [4] 3.0.CO
  • [5] 2-M
  • [6] Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
    Basly, JP
    Marre-Fournier, F
    Le Bail, JC
    Habrioux, G
    Chulia, AJ
    [J]. LIFE SCIENCES, 2000, 66 (09) : 769 - 777
  • [7] Bertelli A, 1998, DRUG EXP CLIN RES, V24, P133
  • [8] BERTELLI AAE, 1995, INT J TISSUE REACT, V17, P1
  • [9] A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens -: Commentary
    Boettger-Tong, H
    Murthy, L
    Chiappetta, C
    Kirkland, JL
    Goodwin, B
    Adlercreutz, H
    Stancel, GM
    Mäkelä, S
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 (07) : 369 - 373
  • [10] Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β
    Bowers, JL
    Tyulmenkov, VV
    Jernigan, SC
    Klinge, CM
    [J]. ENDOCRINOLOGY, 2000, 141 (10) : 3657 - 3667